These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1028 related items for PubMed ID: 30165035

  • 61. Exosome-derived miR-182-5p promoted cholangiocarcinoma progression and vasculogenesis by regulating ADK/SEMA5a/PI3K pathway.
    Wang J, Jiang W, Liu S, Shi K, Zhang Y, Chen Y, Shan J, Wang Y, Xu X, Li C, Li X.
    Liver Int; 2024 Feb; 44(2):370-388. PubMed ID: 37950359
    [Abstract] [Full Text] [Related]

  • 62. Long noncoding RNA LINC01296 promotes tumor growth and progression by sponging miR-5095 in human cholangiocarcinoma.
    Zhang D, Li H, Xie J, Jiang D, Cao L, Yang X, Xue P, Jiang X.
    Int J Oncol; 2018 Jun; 52(6):1777-1786. PubMed ID: 29620172
    [Abstract] [Full Text] [Related]

  • 63. MicroRNA-27a-3p targets FoxO signalling to induce tumour-like phenotypes in bile duct cells.
    Duwe L, Munoz-Garrido P, Lewinska M, Lafuente-Barquero J, Satriano L, Høgdall D, Taranta A, Nielsen BS, Ghazal A, Matter MS, Banales JM, Aldana BI, Gao YT, Marquardt JU, Roberts LR, Oliveira RC, Koshiol J, O'Rourke CJ, Andersen JB.
    J Hepatol; 2023 Feb; 78(2):364-375. PubMed ID: 36848245
    [Abstract] [Full Text] [Related]

  • 64. Expression profile of microRNA-200 family in cholangiocarcinoma arising from choledochal cyst.
    Chu CH, Chou W, Wang F, Yeh CN, Chen TC, Yeh TS.
    J Gastroenterol Hepatol; 2016 May; 31(5):1052-9. PubMed ID: 26479153
    [Abstract] [Full Text] [Related]

  • 65. Systemic analysis of the prognostic significance and interaction network of miR-26b-3p in cholangiocarcinoma.
    Yan X, Hu Z, Li X, Liang J, Zheng J, Gong J, Hu K, Sui X, Li R.
    Appl Biochem Biotechnol; 2024 Jul; 196(7):4166-4187. PubMed ID: 37914963
    [Abstract] [Full Text] [Related]

  • 66. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
    Zhou X, Lu Z, Wang T, Huang Z, Zhu W, Miao Y.
    Gene; 2018 Oct 05; 673():181-193. PubMed ID: 29913239
    [Abstract] [Full Text] [Related]

  • 67. Role of exosomal microRNA-125b-5p in conferring the metastatic phenotype among pancreatic cancer cells with different potential of metastasis.
    Wu M, Tan X, Liu P, Yang Y, Huang Y, Liu X, Meng X, Yu B, Wu Y, Jin H.
    Life Sci; 2020 Aug 15; 255():117857. PubMed ID: 32470446
    [Abstract] [Full Text] [Related]

  • 68. MicroRNA profiling of human intrahepatic cholangiocarcinoma cell lines reveals biliary epithelial cell-specific microRNAs.
    Kawahigashi Y, Mishima T, Mizuguchi Y, Arima Y, Yokomuro S, Kanda T, Ishibashi O, Yoshida H, Tajiri T, Takizawa T.
    J Nippon Med Sch; 2009 Aug 15; 76(4):188-97. PubMed ID: 19755794
    [Abstract] [Full Text] [Related]

  • 69. Meta-analysis of gene expression profiles identifies differential biomarkers for hepatocellular carcinoma and cholangiocarcinoma.
    Likhitrattanapisal S, Tipanee J, Janvilisri T.
    Tumour Biol; 2016 Sep 15; 37(9):12755-12766. PubMed ID: 27448818
    [Abstract] [Full Text] [Related]

  • 70. Exosomal miR-423-5p targets SUFU to promote cancer growth and metastasis and serves as a novel marker for gastric cancer.
    Yang H, Fu H, Wang B, Zhang X, Mao J, Li X, Wang M, Sun Z, Qian H, Xu W.
    Mol Carcinog; 2018 Sep 15; 57(9):1223-1236. PubMed ID: 29749061
    [Abstract] [Full Text] [Related]

  • 71. Concomitant dysregulation of microRNAs miR-151-3p and miR-126 correlates with improved survival in resected cholangiocarcinoma.
    McNally ME, Collins A, Wojcik SE, Liu J, Henry JC, Jiang J, Schmittgen T, Bloomston M.
    HPB (Oxford); 2013 Apr 15; 15(4):260-4. PubMed ID: 23458262
    [Abstract] [Full Text] [Related]

  • 72. miR-26a induced the suppression of tumor growth of cholangiocarcinoma via KRT19 approach.
    Wang P, Lv L.
    Oncotarget; 2016 Dec 06; 7(49):81367-81376. PubMed ID: 27833076
    [Abstract] [Full Text] [Related]

  • 73. Tumor-derived exosomal miR-619-5p promotes tumor angiogenesis and metastasis through the inhibition of RCAN1.4.
    Kim DH, Park S, Kim H, Choi YJ, Kim SY, Sung KJ, Sung YH, Choi CM, Yun M, Yi YS, Lee CW, Kim SY, Lee JC, Rho JK.
    Cancer Lett; 2020 Apr 10; 475():2-13. PubMed ID: 32004570
    [Abstract] [Full Text] [Related]

  • 74. Intracellular and exosomal microRNAome profiling of human vascular smooth muscle cells during replicative senescence.
    Nguyen DDN, Zain SM, Kamarulzaman MH, Low TY, Chilian WM, Pan Y, Ting KN, Hamid A, Abdul Kadir A, Pung YF.
    Am J Physiol Heart Circ Physiol; 2021 Oct 01; 321(4):H770-H783. PubMed ID: 34506226
    [Abstract] [Full Text] [Related]

  • 75. miR-28-5p inhibits cholangiocarcinoma progression and predicts good prognosis of patients.
    Chen T, Wang H, Yan H.
    Cell Cycle; 2022 Oct 01; 21(19):2079-2090. PubMed ID: 35670491
    [Abstract] [Full Text] [Related]

  • 76. Upregulation of miR‑132‑3p in cholangiocarcinoma tissues: A study based on RT‑qPCR, The Cancer Genome Atlas miRNA sequencing, Gene Expression Omnibus microarray data and bioinformatics analyses.
    Wu HY, Xia S, Liu AG, Wei MD, Chen ZB, Li YX, He Y, Liao MJ, Hu QP, Pan SL.
    Mol Med Rep; 2019 Dec 01; 20(6):5002-5020. PubMed ID: 31638221
    [Abstract] [Full Text] [Related]

  • 77. Identification of a novel microRNA signature associated with intrahepatic cholangiocarcinoma (ICC) patient prognosis.
    Zhang MY, Li SH, Huang GL, Lin GH, Shuang ZY, Lao XM, Xu L, Lin XJ, Wang HY, Li SP.
    BMC Cancer; 2015 Feb 18; 15():64. PubMed ID: 25880914
    [Abstract] [Full Text] [Related]

  • 78. MicroRNA (miR)-433 and miR-22 dysregulations induce histone-deacetylase-6 overexpression and ciliary loss in cholangiocarcinoma.
    Mansini AP, Lorenzo Pisarello MJ, Thelen KM, Cruz-Reyes M, Peixoto E, Jin S, Howard BN, Trussoni CE, Gajdos GB, LaRusso NF, Perugorria MJ, Banales JM, Gradilone SA.
    Hepatology; 2018 Aug 18; 68(2):561-573. PubMed ID: 29406621
    [Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80. Expression and Clinical Pathological Significance of miR-200a in Concurrent Cholangiocarcinoma Associated with Hepatolithiasis.
    Chen C, Yang D, Wang Q, Wang X.
    Med Sci Monit; 2015 Nov 20; 21():3585-90. PubMed ID: 26586458
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 52.